| scholarly article | Q13442814 |
| P50 | author | Josephine M. Forbes | Q17517073 |
| Melinda T Coughlan | Q85508080 | ||
| P2093 | author name string | Hermann Haller | |
| Harald H H W Schmidt | |||
| Mark E Cooper | |||
| David Barit | |||
| Jay C Jha | |||
| Karin A M Jandeleit-Dahm | |||
| Stephen P Gray | |||
| Vicki Thallas-Bonke | |||
| P2860 | cites work | Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration | Q27323209 |
| Free radicals in the physiological control of cell function | Q27860480 | ||
| The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology | Q27860991 | ||
| Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis | Q28216384 | ||
| Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications | Q28268182 | ||
| Oxidative stress as a major culprit in kidney disease in diabetes | Q28281957 | ||
| Subcellular localization of Nox4 and regulation in diabetes | Q28566200 | ||
| Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway | Q28571271 | ||
| Global estimates of the prevalence of diabetes for 2010 and 2030 | Q29547218 | ||
| Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage | Q29616101 | ||
| The pathobiology of diabetic complications: a unifying mechanism | Q29617766 | ||
| Production and actions of superoxide in the renal medulla | Q30662153 | ||
| Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy | Q33660629 | ||
| Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications | Q34049428 | ||
| Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications | Q34287894 | ||
| Roles of mitochondria in health and disease. | Q35641708 | ||
| NADPH oxidases in the kidney | Q36598811 | ||
| Renal microvascular injury in diabetes: RAGE and redox signaling. | Q36690238 | ||
| Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy | Q37065902 | ||
| RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. | Q37146417 | ||
| Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions | Q37475632 | ||
| Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression | Q37670311 | ||
| Redox control of protein kinase C: cell- and disease-specific aspects | Q37688100 | ||
| Nox as a target for diabetic complications | Q38114488 | ||
| Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy. | Q39349244 | ||
| Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy | Q42970293 | ||
| Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. | Q43020318 | ||
| Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. | Q43218267 | ||
| Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy | Q44599806 | ||
| Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content | Q44633271 | ||
| Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. | Q44953934 | ||
| Effects of NADPH oxidase inhibitor in diabetic nephropathy | Q46445328 | ||
| Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. | Q46579574 | ||
| Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression | Q46677686 | ||
| Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney | Q46681131 | ||
| Role of Nox4 in murine models of kidney disease. | Q47430771 | ||
| Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. | Q53589254 | ||
| Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. | Q54574472 | ||
| Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy? | Q61512804 | ||
| Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia | Q72019101 | ||
| A noninvasive computerized tail-cuff system for measuring blood pressure in mice | Q72210808 | ||
| Role of oxidative stress in diabetic complications: a new perspective on an old paradigm | Q77804864 | ||
| Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model | Q79678201 | ||
| Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice | Q80305250 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nitrogen oxide | Q424418 |
| P577 | publication date | 2014-11-03 | |
| P1433 | published in | Physiological Reports | Q15716763 |
| P1476 | title | Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy | |
| P478 | volume | 2 |
| Q63916411 | A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes |
| Q64100477 | AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways |
| Q52724019 | Acute Kidney Injury and Progression of Diabetic Kidney Disease. |
| Q62936515 | Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke |
| Q38758929 | Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology |
| Q92545357 | Couplet medicines of leech and centipede granules improve erectile dysfunction via inactivation of the CaSR/PLC/PKC signaling in streptozotocin-induced diabetic rats |
| Q50092600 | Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4. |
| Q37349206 | Diabetes and Kidney Disease: Role of Oxidative Stress |
| Q37597721 | Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury |
| Q92445964 | Flavin Oxidase-Induced ROS Generation Modulates PKC Biphasic Effect of Resveratrol on Endothelial Cell Survival |
| Q38785627 | Hydrogen Sulfide in Renal Physiology and Disease |
| Q46419349 | Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells |
| Q36464709 | Influence of protein kinase C (PKC) on the prognosis of diabetic nephropathy patients |
| Q46499634 | Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis |
| Q52680904 | Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease. |
| Q41181776 | Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury |
| Q35824748 | Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors |
| Q28385322 | Obesity and Diabetic Kidney Disease: Role of Oxidant Stress and Redox Balance |
| Q92290748 | Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread |
| Q47642456 | Oxidative stress induces renal failure: A review of possible molecular pathways. |
| Q54110304 | Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction. |
| Q46648044 | Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy |
| Q98158779 | Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway |
| Q47231510 | Potein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. |
| Q38701033 | Resveratrol ameliorates diabetic nephropathy in rats through negative regulation of the p38 MAPK/TGF-β1 pathway |
| Q35671828 | Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes |
| Q51210259 | The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age. |
| Q38883369 | Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease |
| Q46386818 | Tiron ameliorates high glucose-induced cardiac myocyte apoptosis by PKCδ-dependent inhibition of osteopontin |
| Q35450699 | Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease |
| Q92434021 | iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy |
Search more.